Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer

Journal of Oncology

Volumn , Issue , 2011, Pages

  Steffensen, Karina Dahl ^a,b   Alvero, Ayesha B ^c   Yang, Yang ^c   Waldstrøm, Marianne ^a   Hui, Pei ^c   Holmberg, Jennie C ^c   Silasi, Dan Arin ^c   Jakobsen, Anders ^a,b   Rutherford, Thomas ^c   Mor, Gil ^c  

^a LILLEBAELT HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYTOKERATIN 18; HERMES ANTIGEN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CELL COUNT; CELL DIFFERENTIATION; EPITHELIAL OVARIAN CANCER STEM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OVARY CANCER; PREVALENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 81555220068     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2011/620523     Document Type: Article

References (48)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. J., Cancer statistics, 2009 CA Cancer Journal for Clinicians 2009 59 4 225 249
2. Schwartz P. E., Current diagnosis and treatment modalities for ovarian cancer Cancer Treatment and Research 2002 107 99 118
3. Piver M. S., Muggia F. M., Brady M. F., Alvarez R., Maintenance chemotherapy in advanced ovarian cancer Journal of Clinical Oncology 2000 18 8 1803 1805 (Pubitemid 30220563)
4. Rose P. G., Chemotherapy for newly diagnosed and relapsed advanced ovarian cancer Seminars in Oncology Nursing 2003 19 2 25 35 (Pubitemid 40434444)
5. Seiden M. V., Ovarian cancer Oncologist 2001 6 4 327 332 (Pubitemid 32816536)
6. Reya T., Morrison S. J., Clarke M. F., Weissman I. L., Stem cells, cancer, and cancer stem cells Nature 2001 414 6859 105 111 (Pubitemid 33041634)
7. Huang E. H., Heidt D. G., Li C. W., Simeone D. M., Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance Surgery 2007 141 4 415 419 (Pubitemid 46441320)
8. Maitland N. J., Bryce S. D., Stower M. J., Collins A. T., Prostate cancer stem cells: a target for new therapies Ernst Schering Foundation Symposium Proceedings 2006 5 155 179
9. Maitland N. J., Collins A., A tumour stem cell hypothesis for the origins of prostate cancer BJU International 2005 96 9 1219 1223 (Pubitemid 41743913)
10. Dean M., Fojo T., Bates S., Tumour stem cells and drug resistance Nature Reviews Cancer 2005 5 4 275 284 (Pubitemid 40488633)
11. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M. A., Dick J. E., A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 1994 367 6464 645 648 (Pubitemid 24067706)
12. Vormoor J., Lapidot T., Pflumio F., Risdon G., Patterson B., Broxmeyer H. E., Dick J. E., SCID mice as an in vivo model of human cord blood hematopoiesis Blood Cells 1994 20 2-3 316 320
13. Morrison R., Schleicher S. M., Sun Y., Niermann K. J., Kim S., Spratt D. E., Chung C. H., Lu B., Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis Journal of Oncology 2011 2011 13
14. Alvero A. B., Chen R., Fu H. H., Montagna M., Schwartz P. E., Rutherford T., Silasi D. A., Steffensen K. D., Waldstrom M., Visintin I., Mor G., Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance Cell Cycle 2009 8 1 158 166
15. Mor G., Yin G., Chefetz I., Yang Y., Alvero A., Ovarian cancer stem cells and inflammation Cancer Biology and Therapy 2011 11 8 708 713
16. Bapat S. A., Mali A. M., Koppikar C. B., Kurrey N. K., Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer Cancer Research 2005 65 8 3025 3029 (Pubitemid 40524578)
17. Kurrey N. K., Amit K., Bapat S. A., Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level Gynecologic Oncology 2005 97 1 155 165 (Pubitemid 40403688)
18. Zhang S., Balch C., Chan M. W., Lai H. C., Matei D., Schilder J. M., Yan P. S., Huang T. H. M., Nephew K. P., Identification and characterization of ovarian cancer-initiating cells from primary human tumors Cancer Research 2008 68 11 4311 4320
19. Deng S., Yang X., Lassus H., Liang S., Kaur S., Ye Q., Li C., Wang L. P., Roby K. F., Orsulic S., Connolly D. C., Zhang Y., Montone K., Btzow R., Coukos G., Zhang L., Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers PLoS ONE 2010 5 4
20. Silva I. A., Bai S., McLean K., Aldehyde dehydrogenase and CD133 define angiogenic ovarian cancer stem cells that portend poor patient survival Cancer Research 2011 71 11 3991 4001
21. Dyall S., Gayther S. A., Dafou D., Cancer stem cells and epithelial ovarian cancer Journal of Oncology 2010 2010 9
22. Alvero A. B., Fu H. H., Holmberg J., Visintin I., Mor L., Marquina C. C., Oidtman J., Silasi D. A., Mor G., Stem-like ovarian cancer cells can serve as tumor vascular progenitors Stem Cells 2009 27 10 2405 2413
23. Ray P., Tsien R., Gambhir S. S., Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects Cancer Research 2007 67 7 3085 3093 (Pubitemid 46724845)
24. Massoud T. F., Paulmurugan R., De A., Ray P., Gambhir S. S., Reporter gene imaging of protein-protein interactions in living subjects Current Opinion in Biotechnology 2007 18 1 31 37 (Pubitemid 46227972)
25. Kamsteeg M., Rutherford T., Sapi E., Hanczaruk B., Shahabi S., Flick M., Brown D., Mor G., Phenoxodiolan isoflavone analoginduces apoptosis in chemoresistant ovarian cancer cells Oncogene 2003 22 17 2611 2620 (Pubitemid 36605609)
26. Rustin G. J., Use of CA-125 to assess response to new agents in ovarian cancer trials Journal of Clinical Oncology 2003 21 10 187 193
27. Rustin G. J., Nelstrop A. E., McClean P., Brady M. F., McGuire W. P., Hoskins W. J., Mitchell H., Lambert H. E., Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125 Journal of Clinical Oncology 1996 14 5 1545 1551 (Pubitemid 26134212)
28. Shimizu Y., Kamoi S., Amada S., Hasumi K., Akiyama F., Silverberg S. G., Toward the development of a universal grading system for ovarian epithelial carcinoma I. Prognostic significance of histopathologic features-problems involved in the architectural grading system Gynecologic Oncology 1998 70 1 2 12 (Pubitemid 28368866)
29. Leedham S. J., Brittan M., McDonald S. A., Wright N. A., Intestinal stem cells Journal of Cellular and Molecular Medicine 2005 9 1 11 24
30. Clarke M. F., Fuller M., Stem cells and cancer: two faces of eve Cell 2006 124 6 1111 1115
31. Singh S. K., Clarke I. D., Terasaki M., Bonn V. E., Hawkins C., Squire J., Dirks P. B., Identification of a cancer stem cell in human brain tumors Cancer Research 2003 63 18 5821 5828 (Pubitemid 37187480)
32. Cho R. W., Wang X., Diehn M., Shedden K., Chen G. Y., Sherlock G., Gurney A., Lewicki J., Clarke M. F., Isolation and molecular characterization of cancer stem cells in MMTV- Wnt-1 murine breast tumors Stem Cells 2008 26 2 364 371 (Pubitemid 351413596)
33. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A., Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Research 2004 64 19 7011 7021 (Pubitemid 39331011)
34. Carlson J. W., Miron A., Jarboe E. A., Parast M. M., Hirsch M. S., Lee Y., Muto M. G., Kindelberger D., Crum C. P., Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention Journal of Clinical Oncology 2008 26 25 4160 4165
35. Jarboe E. A., Folkins A. K., Drapkin R., Ince T. A., Agoston E. S., Crum C. P., Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective Histopathology 2008 53 2 127 138 (Pubitemid 352032762)
36. Chen R., Alvero A. B., Silasi D. A., Kelly M. G., Fest S., Visintin I., Leiser A., Schwartz P. E., Rutherford T., Mor G., Regulation of IKK by miR-199a affects NF- B activity in ovarian cancer cells Oncogene 2008 27 34 4712 4723
37. Kelly M. G., Alvero A. B., Chen R., Silasi D. A., Abrahams V. M., Chan S., Visintin I., Rutherford T., Mor G., TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer Cancer Research 2006 66 7 3859 3868
38. Chen R., Alvero A. B., Silasi D. A., Steffensen K. D., Mor G., Cancers take their Tollthe function and regulation of Toll-like receptors in cancer cells Oncogene 2008 27 2 225 233
39. Yin G., Chen R., Alvero A. B., Fu H. H., Holmberg J., Glackin C., Rutherford T., Mor G., TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214 Oncogene 2010 29 24 3545 3553
40. Leedham S. J., Thliveris A. T., Halberg R. B., Newton M. A., Wright N. A., Gastrointestinal stem cells and cancer: bridging the molecular gap Stem Cell Reviews 2005 1 3 233 242 (Pubitemid 41737100)
41. Leedham S. J., Wright N. A., Expansion of a mutated clone: from stem cell to tumour Journal of Clinical Pathology 2008 61 2 164 171 (Pubitemid 351218875)
42. Yauch R. L., Gould S. E., Scales S. J., Tang T., Tian H., Ahn C. P., Marshall D., Fu L., Januario T., Kallop D., Nannini-Pepe M., Kotkow K., Marsters J. C., Rubin L. L., De Sauvage F. J., A paracrine requirement for hedgehog signalling in cancer Nature 2008 455 7211 406 410
43. Naor D., Sionov R. V., Ish-Shalom D., CD44: structure, function, and association with the malignant process Advances in Cancer Research 1997 71 241 319 (Pubitemid 27197761)
44. Uhi-Steidl M., Muller-Holzner E., Zeimet A. G., Adolf G. R., Daxenbichler G., Marth C., Dapunt O., Prognostic value of CD44 splice variant expression in ovarian cancer Oncology 1995 52 5 400 406
45. Kayastha S., Freedman A. N., Piver M. S., Mukkamalla J., Romero-Guittierez M., Werness B. A., Expression of the hyaluronan receptor, CD44s, in epithelial ovarian cancer is an independent predictor of survival Clinical Cancer Research 1999 5 5 1073 1076 (Pubitemid 29233221)
46. Rodrguez-Rodrguez L., Sancho-Torres I., Mesonero C., Gibbon D. G., Shih W. J., Zotalis G., The CD44 receptor is a molecular predictor of survival in ovarian cancer Medical Oncology 2003 20 3 255 263 (Pubitemid 37193937)
47. Ricciardelli C., Rodgers R. J., Extracellular matrix of ovarian tumors Seminars in Reproductive Medicine 2006 24 4 270 282 (Pubitemid 44389345)
48. Sionov R. V., Naor D., Hyaluronan-independent lodgment of CD44 + lymphoma cells in lymphoid organs International Journal of Cancer 1997 71 3 462 469 (Pubitemid 27224314)